Insulin aspart, recombinant Subcutaneous and Sapropterin Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Sapropterin Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: sapropterin
Brand name: Kuvan
Synonyms: Sapropterin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Saquinavir
- Insulin aspart, recombinant Subcutaneous-Sarafem
- Insulin aspart, recombinant Subcutaneous-Sarafem Tablets
- Insulin aspart, recombinant Subcutaneous-Sarecycline
- Insulin aspart, recombinant Subcutaneous-Sarecycline Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Sargramostim
- Sapropterin Tablets-Insulin degludec
- Sapropterin Tablets-Insulin Degludec (U-100) Prefilled Pens
- Sapropterin Tablets-Insulin Degludec (U-100) Vials
- Sapropterin Tablets-Insulin Degludec (U-200) Prefilled Pens
- Sapropterin Tablets-Insulin degludec and liraglutide
- Sapropterin Tablets-Insulin degludec and liraglutide Subcutaneous